Enovis Current Ratio 2012-2025 | ENOV
Enovis current ratio from 2012 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Enovis Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-09-30 | $1.28B | $0.58B | 2.23 |
| 2025-06-30 | $1.28B | $0.57B | 2.25 |
| 2025-03-31 | $1.22B | $0.48B | 2.55 |
| 2024-12-31 | $1.15B | $0.53B | 2.17 |
| 2024-09-30 | $1.20B | $0.53B | 2.27 |
| 2024-06-30 | $1.17B | $0.52B | 2.26 |
| 2024-03-31 | $1.15B | $0.55B | 2.10 |
| 2023-12-31 | $0.90B | $0.37B | 2.43 |
| 2023-09-30 | $0.85B | $0.36B | 2.40 |
| 2023-06-30 | $0.89B | $0.35B | 2.51 |
| 2023-03-31 | $0.83B | $0.35B | 2.38 |
| 2022-12-31 | $0.80B | $0.57B | 1.41 |
| 2022-09-30 | $1.01B | $0.85B | 1.18 |
| 2022-06-30 | $1.08B | $0.81B | 1.33 |
| 2022-03-31 | $2.35B | $1.45B | 1.62 |
| 2021-12-31 | $2.30B | $1.02B | 2.25 |
| 2021-09-30 | $1.73B | $0.98B | 1.77 |
| 2021-06-30 | $1.48B | $0.90B | 1.64 |
| 2021-03-31 | $2.08B | $1.56B | 1.33 |
| 2020-12-31 | $1.36B | $0.81B | 1.68 |
| 2020-09-30 | $1.29B | $0.79B | 1.64 |
| 2020-06-30 | $1.23B | $0.76B | 1.62 |
| 2020-03-31 | $1.58B | $0.82B | 1.93 |
| 2019-12-31 | $1.40B | $0.86B | 1.64 |
| 2019-09-30 | $3.50B | $1.51B | 2.32 |
| 2019-06-30 | $3.64B | $1.60B | 2.28 |
| 2019-03-31 | $2.41B | $1.57B | 1.53 |
| 2018-12-31 | $1.96B | $1.20B | 1.63 |
| 2018-09-30 | $1.95B | $1.07B | 1.83 |
| 2018-06-30 | $1.95B | $1.08B | 1.81 |
| 2018-03-31 | $2.16B | $1.10B | 1.98 |
| 2017-12-31 | $2.07B | $1.10B | 1.89 |
| 2017-09-30 | $2.32B | $1.29B | 1.80 |
| 2017-06-30 | $1.96B | $1.15B | 1.71 |
| 2017-03-31 | $1.78B | $1.08B | 1.65 |
| 2016-12-31 | $1.74B | $1.06B | 1.64 |
| 2016-09-30 | $1.80B | $1.08B | 1.68 |
| 2016-06-30 | $1.79B | $1.09B | 1.64 |
| 2016-03-31 | $1.79B | $1.10B | 1.63 |
| 2015-12-31 | $1.73B | $1.12B | 1.55 |
| 2015-09-30 | $2.00B | $1.21B | 1.66 |
| 2015-06-30 | $2.01B | $1.20B | 1.67 |
| 2015-03-31 | $2.02B | $1.26B | 1.61 |
| 2014-12-31 | $2.07B | $1.28B | 1.62 |
| 2014-09-30 | $2.22B | $1.37B | 1.62 |
| 2014-06-30 | $2.41B | $1.42B | 1.70 |
| 2014-03-31 | $2.34B | $1.31B | 1.78 |
| 2013-12-31 | $2.13B | $1.38B | 1.54 |
| 2013-09-30 | $2.37B | $1.32B | 1.79 |
| 2013-06-30 | $2.29B | $1.25B | 1.83 |
| 2013-03-31 | $1.99B | $1.27B | 1.57 |
| 2012-12-31 | $2.13B | $1.18B | 1.80 |
| 2012-09-30 | $2.23B | $1.22B | 1.83 |
| 2012-06-30 | $2.30B | $1.24B | 1.86 |
| 2012-03-31 | $2.34B | $1.20B | 1.95 |
| 2011-12-31 | $0.35B | $0.24B | 1.46 |
| 2011-09-30 | $0.35B | $0.21B | 1.63 |
| 2011-06-30 | $0.34B | $0.21B | 1.67 |
| 2011-03-31 | $0.33B | $0.21B | 1.61 |
| 2010-12-31 | $0.32B | $0.19B | 1.68 |
| 2010-09-30 | $0.29B | $0.17B | 1.72 |
| 2010-06-30 | $0.28B | $0.14B | 1.95 |
| 2010-03-31 | $0.29B | $0.15B | 1.94 |
| 2009-12-31 | $0.30B | $0.15B | 1.97 |
| 2009-09-30 | $0.31B | $0.16B | 1.99 |
| 2009-06-30 | $0.29B | $0.14B | 2.07 |
| 2009-03-31 | $0.28B | $0.14B | 2.02 |
| 2008-12-31 | $0.30B | $0.15B | 1.91 |
| 2008-09-30 | $0.32B | $0.17B | 1.89 |
| 2008-06-30 | $0.31B | $0.16B | 1.94 |
| 2008-03-31 | $0.30B | $0.19B | 1.58 |
| 2007-12-31 | $0.29B | $0.15B | 1.94 |
| 2007-09-30 | $0.00B | 0.00 | |
| 2007-06-30 | $0.00B | 0.00 | |
| 2007-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.291B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $30.738B | 35.55 |
| Tempus AI (TEM) | United States | $9.941B | 0.00 |
| Doximity (DOCS) | United States | $5.129B | 21.79 |
| IRhythm Holdings (IRTC) | United States | $4.904B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.925B | 31.93 |
| Privia Health (PRVA) | United States | $2.684B | 167.85 |
| Hinge Health (HNGE) | United States | $2.602B | 0.00 |
| 10x Genomics (TXG) | United States | $2.423B | 0.00 |
| Heartflow (HTFL) | United States | $2.325B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.980B | 32.76 |
| Omnicell (OMCL) | United States | $1.750B | 48.75 |
| Azenta (AZTA) | United States | $1.381B | 55.54 |
| Clover Health Investments (CLOV) | United States | $1.095B | 0.00 |
| Schrodinger (SDGR) | United States | $1.004B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.861B | 0.00 |
| Phreesia (PHR) | United States | $0.748B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.713B | 0.00 |
| Talkspace (TALK) | United States | $0.646B | 130.00 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Claritev (CTEV) | United States | $0.365B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.338B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.334B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.323B | 0.00 |
| Carlsmed (CARL) | United States | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.305B | 0.00 |
| TruBridge (TBRG) | United States | $0.285B | 13.10 |
| CapsoVision (CV) | United States | $0.220B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.212B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.171B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.158B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.146B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 5.49 |
| Outset Medical (OM) | United States | $0.085B | 0.00 |
| American Well (AMWL) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Pulmonx (LUNG) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| Precipio (PRPO) | United States | $0.037B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.016B | 0.00 |
| Movano (MOVE) | United States | $0.015B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.006B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.006B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |